Subscribe (Free) to
Daily or Weekly Newsletters
Post a Job

Featured Jobs

Account Manager

MAP Retirement USA, LLC

MAP Retirement USA, LLC logo

Plan Document Specialist

MAP Retirement USA LLC

MAP Retirement USA LLC logo

Employee Benefits Account Manager

U.S. Retirement & Benefits Partners
(Midland TX)

U.S. Retirement & Benefits Partners logo

Client Service Specialist

July Business Services
(Remote / Waco TX)

July Business Services logo

Participant Services Associate

July Business Services

July Business Services logo

Retirement Plan Consultant

July Business Services

July Business Services logo

Implementation Specialist

Nova 401(k) Associates

Nova 401(k) Associates logo

ERISA Partner

(Remote / Atlanta GA)

HBL logo

Team Leader - Compliance & Relationship Management

Compass Retirement Consulting Group, Inc.

Compass Retirement Consulting Group, Inc. logo

Defined Contribution Account Manager

Nova 401(k) Associates

Nova 401(k) Associates logo

Document Specialist

PlanPerfect, Inc.

PlanPerfect, Inc. logo

View More Employee Benefits Jobs

Free Newsletters

“BenefitsLink continues to be the most valuable resource we have at the firm.”

-- An attorney subscriber

Mobile App image
LinkedIn icon     Twitter icon     Facebook icon
and Podcasts
  >  Upcoming   |   Recorded
(In-Person or Virtual)
  >  Upcoming   |   Grouped by Location
All   >  Upcoming   |   Grouped by Sponsor

View More Segal Webinars, Podcasts and Conferences

New Drugs for Weight Loss: What Plan Sponsors Need to Know


May 24, 2023
Recorded Online

The latest generation of prescription drugs originally developed to help people manage their type 2 diabetes, such as Ozempic®, have been causing quite a stir for patients, health professionals and benefit plans now that some have been both approved and promoted for treating obesity. The effectiveness of and demand for these newer drugs are prompting some plan sponsors that exclude anti-obesity drugs from coverage to revisit plan rules. However, there are concerns about the potentially large target patient population, as well as the increased utilization and the high cost of these drugs.

You’re invited to join a webinar that will address the range of issues plan sponsors face related to weight-loss benefits and potential coverage of newer anti-obesity drug therapies.

You’ll gain an understanding of

  • The history behind glucagon-like peptide-1 or GLP-1 medications and their on- and off-label use
  • How GLP-1 medication usage trends are impacting benefit plans
  • Ways to better manage the rising utilization and cost of GLP-1 medications
  • How federal laws like the Mental Health Parity and Addiction Equity Act affect coverage decisions
  • What to consider before deciding to cover anti-obesity medications, including the importance of incorporating behavioral health programs into your strategy

More Information, How to Register

© 2023, Inc.